Ubiquinol (Reduced COQ10) for Patients With Sepsis

Trial Profile

Ubiquinol (Reduced COQ10) for Patients With Sepsis

Phase of Trial: Phase II

Latest Information Update: 05 May 2017

At a glance

  • Drugs Ubidecarenone (Primary)
  • Indications Sepsis
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 04 Sep 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 17 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top